Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 18, 2021

SELL
$110.2 - $156.64 $8,265 - $11,747
-75 Closed
0 $0
Q4 2019

Jan 08, 2020

SELL
$36.68 - $73.13 $4,071 - $8,117
-111 Reduced 59.68%
75 $5,000
Q3 2018

Oct 25, 2018

BUY
$44.35 - $65.71 $3,326 - $4,928
75 Added 67.57%
186 $8,000
Q1 2018

Apr 19, 2018

BUY
$23.52 - $58.17 $493 - $1,221
21 Added 23.33%
111 $5,000
Q3 2017

Oct 30, 2017

BUY
$16.75 - $20.66 $1,507 - $1,859
90
90 $2,000

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.29B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Cribstone Capital Management, LLC Portfolio

Follow Cribstone Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cribstone Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cribstone Capital Management, LLC with notifications on news.